For research teamsHelp me find a study
Back to all studies
TerminatedNCT03892889

Abilify MyCite® for schizophrenia

This study was terminated in the United States. It is testing abilify MyCite® for schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Abilify MyCite® may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Abilify MyCite®, attend study visits with the research team. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: April 29, 2019
Recruitment status
Terminated
Enrollment listed in the registry
277
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
COMBINATION_PRODUCT
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT03892889
Official title
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 68 sites
  • Alea Research
    Phoenix, Arizona
    Site status: Not listed — confirm with the team
  • Woodland International Research Group
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • ADVANCED RESEARCH CENTER, Inc.
    Anaheim, California
    Site status: Not listed — confirm with the team
  • CITrials
    Bellflower, California
    Site status: Not listed — confirm with the team
  • Synexus
    Cerritos, California
    Site status: Not listed — confirm with the team
  • CMB Clinical Trials
    Colton, California
    Site status: Not listed — confirm with the team
  • ProScience Research Group
    Culver City, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network, LLC
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • Behavioral Research Specialists, LLC
    Glendale, California
    Site status: Not listed — confirm with the team
  • San Fernando Mental Health Center
    Granada Hills, California
    Site status: Not listed — confirm with the team
  • Om Research LLC
    Lancaster, California
    Site status: Not listed — confirm with the team
  • Synergy San Diego
    Lemon Grove, California
    Site status: Not listed — confirm with the team
  • CalNeuro Research Group
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Pacific Research Partners
    Oakland, California
    Site status: Not listed — confirm with the team
  • Excell Research, Inc
    Oceanside, California
    Site status: Not listed — confirm with the team
  • CNRI-Los Angeles
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • Prospective Research Innovations Inc.
    Rancho Cucamonga, California
    Site status: Not listed — confirm with the team
  • CITrials
    Riverside, California
    Site status: Not listed — confirm with the team
  • CNRI-San Diego, LLC
    San Diego, California
    Site status: Not listed — confirm with the team
  • Artemis Institute for Clinical Research
    San Diego, California
    Site status: Not listed — confirm with the team
  • CITrials, Inc.
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • Siyan Clinical Research
    Santa Rosa, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network, LLC
    Torrance, California
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Trials
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Indago Research & Health Center, Inc.
    Hialeah, Florida
    Site status: Not listed — confirm with the team
  • New Life medical Research Inc.
    Hialeah, Florida
    Site status: Not listed — confirm with the team
  • Galiz Research
    Hialeah, Florida
    Site status: Not listed — confirm with the team
  • Innovative Clinical Research, Inc.
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Premier Clinical Research Institute Inc.
    Miami, Florida
    Site status: Not listed — confirm with the team
  • CCM Clinical Research Group
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Prestige Clinical Research Center Inc.
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Stedman Clinical Tirlas
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Nova Psychiatry, Inc
    Winter Park, Florida
    Site status: Not listed — confirm with the team
  • Emory
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Synexus Clinical Research US
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • iResearch Atlanta
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • iResearch Savannah
    Savannah, Georgia
    Site status: Not listed — confirm with the team
  • Uptown Research Institute
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • AMITA Health
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • SIU School of Medicine
    Springfield, Illinois
    Site status: Not listed — confirm with the team
  • Lake Charles Clinical Trial
    Lake Charles, Louisiana
    Site status: Not listed — confirm with the team
  • Michigan Clinical Research Institute
    Ann Arbor, Michigan
    Site status: Not listed — confirm with the team
  • Precise Research Centers
    Flowood, Mississippi
    Site status: Not listed — confirm with the team
  • Arch Clinical Trials, LLC
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • PsychCare Consultants Research
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Alivation Research, LLC.
    Lincoln, Nebraska
    Site status: Not listed — confirm with the team
  • Altea Research Institute
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Kolade Research Institute/Cal Psychiatric Services
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Hassman Research Institute
    Berlin, New Jersey
    Site status: Not listed — confirm with the team
  • Synexus US
    Jamaica, New York
    Site status: Not listed — confirm with the team
  • Manhattan Psychiatric Center
    New York, New York
    Site status: Not listed — confirm with the team
  • Manhattan Behavioral Medicine PLLC
    New York, New York
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Richmond Behavioral Associates
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Midwest Clinical Research Center
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • Signature Research Associates Inc
    Fairlawn, Ohio
    Site status: Not listed — confirm with the team
  • Charak Clinical research Center
    Garfield Heights, Ohio
    Site status: Not listed — confirm with the team
  • Neuro-Behavioral Clinical Research, Inc.
    North Canton, Ohio
    Site status: Not listed — confirm with the team
  • The Rivus Wellness & Research Institute
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Cutting Edge Research Group
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Suburban Research Associates
    Media, Pennsylvania
    Site status: Not listed — confirm with the team
  • Psychiatric Consultants, PC
    Franklin, Tennessee
    Site status: Not listed — confirm with the team
  • Community Clinical Research, Inc.
    Austin, Texas
    Site status: Not listed — confirm with the team
  • InSite Clinical Research
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Baylor College of Medicine
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research
    Richardson, Texas
    Site status: Not listed — confirm with the team
  • Noetic Psychiatry
    Springville, Utah
    Site status: Not listed — confirm with the team
  • Northwest Clinical Research Center
    Bellevue, Washington
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT03892889. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Abilify MyCite®. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.otsuka.co.jp/en/. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.